New incident report
Incident Report Number: 2024-1481
Registrant Reference Number: 2024-CA-000064
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 200 Plaza Drive, Suite 402
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094
Domestic Animal
Country: CANADA
Prov / State: ONTARIO
PMRA Registration No. 29930 PMRA Submission No. EPA Registration No.
Product Name: Hartz UltraGuard OneSpot Flea and Tick Cat Drops
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Animal's Owner
Cat / Chat
Unknown
1
Male
2
3.6
kg
Skin
Unknown / Inconnu
<=30 min / <=30 min
System
Unknown / Inconnu
No
No
Unknown/Inconnu
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 29-Feb-2024, a 2 year old, approximately 3.6 kilogram, neutered, male, cat of unknown breed, in unknown condition, with no known concomitant medical conditions, was administered 1 tube of Hartz UltraGuard OneSpot Flea and Tick Cat Drops (S Methoprene) via the topical route by the animal owner. Approximately 5 minutes post application, the cat developed drooling, hyperactivity (running around the room) and abnormal behavior (ran away from the animal owner). Approximately 15 minutes post application, the drooling, hyperactivity (running around the room) and abnormal behavior (ran away from the animal owner) resolved. The cat developed redness and irritation of the skin from the top of its head to the shoulders. Some of the redness and irritation was noted where the product was applied but was also spreading out to adjacent skin. Bathing with a liquid dish soap three times to remove the product, applying a cool compress to the affected areas of the skin, offering food and water and consulting with the cat's veterinarian as needed was recommended. No further information was received.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.